Ces radiol. 2009, 63(1):80-88
The combination of the MR imaging, DWI and MR spectroscopy enables to extend the method providing the information on cell and tissue metabolismOriginal article
- 1 Radiodiagnostická klinika 1. LF UK a FN Na Bulovce, Praha
- 2 Ústav radiační onkologie 1. LF UK a FN Na Bulovce, Praha
- 3 MR - Budějovická, MEDICON a.s., Praha
Aim: To evaluate options of the prostate carcinoma diagnostics by means of using new Magnetic Resonance methods.
Materials and method. The Magnetic Resonance Imaging (MR) of pelvis with a special focus on prostate performed between January 2006 and February 2008 was evaluated retrospectively. A diffusion-weighted imaging (DWI) was incorporated into the basic MR protocol with all patients. The MR spectroscopy was used with a few patients. All examinations were carried out by means of 1,5 T MR system a with body-matrix and spine-matrix coil. An endorectal coil was not used.
Results: Out of 48 patients diagnosed with prostate carcinoma, 25 patients (52.1%) were diagnosed with T2 stage, 8 patients (16.7%) with T3a stage and 11 patients (22.9%) with T3b stage.
Four patients had advanced form of T4. The MR was carried out for the purpose of staging preciseness and radiotherapy planning. The MR examination was performed on several patients for primary tumour detection after a few previous negative biopsies.
Keywords: prostate carcinoma, MR imaging, MR spectroscopy, DWI
Accepted: December 15, 2008; Published: March 1, 2009 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Clements R. Prostate Carcinoma. E-medicine 2007: www.emedicine.com/radio/topic574.htm
- Webový portál epidemiologie zhoubných nádorů v České republice, www.svod.cz
- Edelman RR. Clinical Magnetic Resonance Imaging, third edition. Philadelphia: Elselvier 2006; 2910-2922.
- Semelka RC. Abdominal Pelvic MRI, second edition. USA: Willey-Liss 2006; 1179-1203.
- Claus GF, Hricak H, Hattery RR. Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1H MR Spectroscopy. Radiographics 2004; 24: 167-180.
Go to original source...
Go to PubMed...
- Choi JY, Kim KJ, Kim N, Kim W K, Choi KE, et al. Functional MR Imaging of Prostate Cancer. Radiographics 2007; 27: 63-77.
Go to original source...
Go to PubMed...
- Kurhanewicz J, Swanson M, Nelson SJ, Vigneron DB. Combined Magnetic Resonance Imaging and Spectroscopic Imaging Approach to Molecular Imaging of Prostate Cancer. J Magn Reson Imaging 2002; 16(4): 451-463.
Go to original source...
Go to PubMed...
- Menard C, Smith CPI, Somorjai LR, Leboldus L, Patel R, et al. Magnetic Resonance Spectroscopy of the Malignant Prostate Gland after Radiotherapy: A Histopathologic Study of Diagnostic Validity. Int J Radiation Oncology Biol Phys 2001; Vol 50, No 2: 317-323.
Go to original source...
Go to PubMed...
- Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, et al. Prostate Cancer: Localization with Three-dimensional Proton MR Spectroscopic Imaging - Clinicopathologic Study. Radiology 1999; 213: 473-480.
Go to original source...
Go to PubMed...
- Reinsberg AS, Payne SG, Riches FS, Ashley S, Brewater MJ, et al. Combined use of Diffusion-Weighted MRI and 1 H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection. AJR 2007; 188: 91-98.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.